Ireland, Singapore, India Increase Funding for Global Vaccine Alliance

At the Gavi 6.0 High-Level Pledging Summit in Brussels, global leaders, including Ireland, Singapore, and India, increased their financial commitments to Gavi, the Vaccine Alliance, to support immunisation efforts for children in low-income countries from 2026-2030. Ireland pledged €21.6 million, a 20% increase, reaffirming its commitment to global health equity, while Singapore committed US$1 million, emphasizing Gavi's role in vaccine equity and pandemic preparedness. India is expected to contribute $20 million, signaling its support for vaccine equity and protection of its vaccine manufacturing export ecosystem, though this is a smaller amount than the Indian Vaccine Manufacturers Association initially requested. Gavi aims to raise at least $9 billion to immunise 500 million children and avert over 8 million deaths globally, while also addressing ongoing outbreaks like measles and cholera. The European Union, a long-term Gavi partner, pledged €260 million for 2026-2027 and continues to lead efforts in vaccine access, regional manufacturing, and emergency stockpiles. These commitments reflect a shared global priority to ensure equitable vaccine access and improve health outcomes worldwide.